BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Quest for Cures: The Leukemia & Lymphoma Society Seeks to Fund Three Critical Areas of Blood Cancer Research

  March 1, 2013

   · 

  2 min read
• BioMidwest

  Nonin Medical, Inc. Selected as Exclusive Provider of Cerebral/Somatic Oximetry Systems to Leading Pediatric Hospitals in Poland

  March 1, 2013

   · 

  3 min read
• Drug Development

  ADVENTRX Pharmaceuticals Inc. to Develop ANX-188 for Complications of Arterial Disease

  March 1, 2013

   · 

  7 min read
• Business

  Daxor Corporation Announces Filing of Form N-CSR for December 31, 2012 and Volumex Kit Sales for 2012

  March 1, 2013

   · 

  3 min read
• BioForest

  OncoGenex Pharmaceuticals Inc. to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013

  March 1, 2013

   · 

  1 min read
• Pharm Country

  VirtualScopics, LLC Receives Additional Time to Regain Compliance With Nasdaq

  March 1, 2013

   · 

  3 min read
• Drug Development

  Invaron Pharmaceuticals and the Center for Assisted Reproduction (CARE) Initiate Investigator Led Phase III Clinical Study on INVOcell(TM)

  March 1, 2013

   · 

  2 min read
• Bioniche Life Sciences Inc. Release: Vaccination of Cattle to Reduce Public Health Risk of E. coli O157 Featured in the Canadian Journal of Public Health

  March 1, 2013

   · 

  5 min read
• Biotech Beach

  Allergan Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form Merger

  March 1, 2013

   · 

  1 min read
• Edwards Lifesciences Corporation’ Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan

  March 1, 2013

   · 

  1 min read